Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Results from confirmatory phase II study of Aquavan

June 21, 2004

Copaxone PFS available in Europe

June 21, 2004

Targeting of Nurr1 gene promising for Parkinson's disease therapy

June 21, 2004

Data on the pharmacokinetics of ramelteon presented at sleep conference

June 21, 2004

Improved prevention of CINV found with a palonosetron combination therapy

June 21, 2004

Takeda claims novel neurotrophic factor production enhancers

June 18, 2004

Four series of delta opioid ligands prepared by AstraZeneca scientists

June 18, 2004

Novel ecstasy analogues may be promising antiparkinsonian agents

June 18, 2004

Noven and Shire to proceed with further development of MethyPatch

June 18, 2004

Second phase III trial of phenserine for Alzheimer's disease

June 18, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...